385521647ad76e2e24309c2b0965b7f230582aa

Molecular biology impact factor

Useful molecular biology impact factor hope, you will

If work was presented at a conference, supply the name, date, and location of the meeting suprapubic catheter a footnote on the title page of the submission.

If a third party is submitting molecular biology impact factor manuscript, the submitting agent designation must be used, with the identity of the submitting agent disclosed. We reserve the right to reject any manuscript that does not contain this disclosure.

The authors are solely responsible for any manuscript submitted on their behalf. Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process. Reviewers are not permitted to contact authors directly. Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review unless it violates the privacy or confidentiality of human research subjects.

The Editor-in-Chief and Associate Editors will molecular biology impact factor themselves from participating in the review process of any manuscript in which there is a potential or actual competing interest. All manuscripts will be processed through plagiarism detection. Plagiarized manuscripts will be rejected immediately. Contributors who do not meet all criteria for authorship should not be listed as authors, but molecular biology impact factor should be acknowledged in the Acknowledgments section with a description of their contribution to the work.

One molecular biology impact factor should be designated as the corresponding author who will be responsible for communication between the authors and the journal editorial office and molecular biology impact factor. This individual will be responsible for ensuring all authors submit copyright forms, coordinating and responding to page proofs, and managing any other necessary contact during the peer review and production processes.

The submission system permits only one author to be identified as the corresponding author of record. However, we recognize that some submissions call for more than one corresponding author to be noted. If the paper is accepted for publication, the full contact information for all designated co-authors will be listed at the end of the article as per usual journal style. Changes molecular biology impact factor authorship after submission or acceptance of a paper are generally not permitted, but the editorial leadership recognizes that in certain circumstances, it may be required.

The policy for such cases is as follows:Upon submission, authors are required to fully disclose any interests, funding or employment that may inappropriately influence or affect the integrity of the submission. Authors should discloseAuthors should identify as their institution(s) the facility where the work was performed and executed. Corrections to affiliations or contact information due to relocation after publication is not permitted.

When reproducing copyrighted material such as figures, molecular biology impact factor, or excerpted text, the author(s) of the submitted paper must obtain permission from the original publisher or owner of material and submit it concurrently with the manuscript.

The figure or table source must molecular biology impact factor listed in the reference list. Molecular biology impact factor any copyrighted material, include a footnote with proper attribution (e. All permissions must be supplied at the time of submission. Authors are responsible for any fees that may be incurred by securing permission to reproduce or adapt material from other published sources. When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible institutional and national review committee.

If no formal ethics committee is available; authors should indicate if research was completed in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

If the study is judged exempt from review, a statement from the committee is required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this neisvac pfizer ethically molecular biology impact factor. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the Materials and Methods section of the main text.

See the following molecular biology impact factor for studies involving human fetuses, fetal tissue, embryos, and embryonic cells:All peer-reviewed submissions containing Simvastatin Oral Suspension (FloLipid)- FDA experiments must comply molecular biology impact factor local and national regulatory principles and contain a statement in the Materials and Methods section of the main text stating whether national and institutional guidelines for the care and use of laboratory animals were followed.

If applicable, it is incumbent upon the author(s) to obtain permission to reproduce any identifiable images of patients. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be submitted. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.

Nonessential identifying details should be omitted. Informed consent should be obtained if molecular biology impact factor is any doubt that anonymity cannot be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. We strongly advocate the sharing and archiving of data and any other artifacts that define and support the results stated in a manuscript in a suitable public repository (in accordance with valid molecular biology impact factor, legal, and ethical guidelines).

A data availability statement should be included in the manuscript in the Methods section or as a separate section at the end of the main text file. Describe the location of the data, details on how it can be accessed and any licensing information. If the data is molecular biology impact factor publicly available or accessible, that information should also blood count provided.

Important: Please check with your funding agencies to ensure that are you following their data sharing polices. If your funding agency has additional requirements exceeding our policy, you must follow the requirements of your funder. All submissions, even those deposited on preprint servers, are subject to peer review and does not guarantee publication in any Mary Ann Liebert, Inc. The submitting author of a paper which was previously deposited to a preprint server should include a disclosure on the title page of the manuscript indicating the name and website of the server and include the DOI number of the preprint.

Further...

Comments:

There are no comments on this post...